Crocin improves endometriosis by inhibiting cell proliferation and the release of inflammatory factors
article
OA: closed
CC0
⤵ 11 in-corpus citations
AI-generated summary
Crocin treatment reduced endometriosis in vivo by suppressing cell proliferation and the release of pro-inflammatory cytokines.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis is one of the most common diseases in women. Inflammation and angiogenesis have been shown to be important in pathogenesis of endometriosis. Crocin is known as an anti-inflammatory, anti- proliferation substance. This study was designed to assess the potential effects of crocin on endometriosis. We established the mice model of endometriosis and administrated crocin to the mice. We monitored the endometriotic lesion growth, PCNA and VEGF expression in the lesion. We tested the serum levels of inflammatory cytokines in crocin-treated endometriosis mice. Finally we tested the effect of crocin on endothelial cell apoptosis and proliferation, and cytokine production in LPS-stimulated human monocyte. Crocin inhibited lesion growth in endometriosis mice and prevented PCNA and VEGF expression in the lesions. Crocin decreased the levels of inflammatory cytokines including INF-γ, TNF-α, VEGF and IL-6 in serum. Crocin inhibited endothelial cells proliferation but did not cause apoptosis in endothelia cells. Crocin inhibited cytokine production in LPS-stimulated THP-1 cells in vitro. Crocin protected endometriosis by inhibiting endothelial cells proliferation and preventing inflammatory cytokines production.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (43)
- Angiogenesis and Endometriosis via openalex
- Antiangiogenesis Therapy for Endometriosis via openalex
- Anti-TNF-α treatment for pelvic pain associated with endometriosis via openalex
- Cell proliferation is increased in the endometrium of women with endometriosis via openalex
- Clinical immunology<br>Pro-inflammatory cytokines for evaluation of inflammatory status in endometriosis via openalex
- Effect of Vascular Endothelial Growth Factor Inhibition on Endometrial Implant Development in a Murine Model of Endometriosis via openalex
- Endometrial Angiogenesis, Vascular Maturation, and Lymphangiogenesis via openalex
- Endometriosis via openalex
- Endometriosis: Treatment Strategies via openalex
- Enhancement of Human Monocyte and Peritoneal Macrophage Chemiluminescence Activities in Women With Endometriosis via openalex
- Macrophages Are Alternatively Activated in Patients with Endometriosis and Required for Growth and Vascularization of Lesions in a Mouse Model of Disease via openalex
- New considerations for the pathogenesis of endometriosis via openalex
- New medical treatments for endometriosis via openalex
- Serum and peritoneal fluid levels of vascular endothelial growth factor in women with endometriosis. via openalex
- Serum and Peritoneal Fluid Levels of Vascular Endothelial Growth Factor in Women with Endometriosis via openalex
- Use of knockout transgenic mice in the study of endometriosis: insights from mice lacking β2-microglobulin and interleukin-12p40 via openalex
- W2592254068 via openalex
- W2734192772 via openalex
- W2764298290 via openalex
- W2791746598 via openalex
- W2792110517 via openalex
- W6677549387 via openalex
- W6684443073 via openalex
- W6700161591 via openalex
- W6714341644 via openalex
- W6714758501 via openalex
- W6740606423 via openalex
- W6745174688 via openalex
- W1996041232 via openalex
- W2013349112 via openalex
- W2021345772 via openalex
- W2021427714 via openalex
- W2027092108 via openalex
- W2034270403 via openalex
- W2046650238 via openalex
- W2072787769 via openalex
- W2131561597 via openalex
- W2133137182 via openalex
- W2155227851 via openalex
- W2167819300 via openalex
- W2292603158 via openalex
- W2409677875 via openalex
- W2410194753 via openalex
Cited by (12)
- Molecular Insights Into Endometriosis for Early Detection and Therapeutic Targets 2026
- Research progress on natural plant metabolites targeting apoptosis for endometriosis prevention and treatment: a systematic review 2025
- Natural bioactive compounds and herbal medicines targeting common signaling pathways in endometriosis: mechanisms and therapeutic implications 2025
- High intensity interval training is superior to moderate intensity continuous training in enhancing the anti-inflammatory and apoptotic effect of pentoxifylline in the rat model of endometriosis 2023
- Peritoneal immune microenvironment of endometriosis: Role and therapeutic perspectives 2023
- Endometriosis promotes atherosclerosis in a murine model 2022
- SMURF1-mediated ubiquitylation of SHP-1 promotes cell proliferation and invasion of endometrial stromal cells in endometriosis 2021
- Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review 2021
- Imperatorin alleviated endometriosis by inhibiting the activation of PI3K/Akt/NF-κB pathway in rats 2021
- Regulation of Inflammation Pathways and Inflammasome by Sex Steroid Hormones in Endometriosis 2020
- Natural products: Potential lead compounds for the treatment of endometriosis 2019
- Inhibitory effect of genistein on MMP-2 and MMP-9 expression through suppressing NF-κB activity in peritoneum of murine model of endometriosis 2018
Source provenance
- europepmc
- last seen: 2026-08-01T06:07:04.264727+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:19:37.156494+00:00
- unpaywall
- last seen: 2026-07-31T06:42:51.797318+00:00
License: CC0
· commercial use OK